![](https://morningstar-morningstar-prod.web.arc-cdn.net/resizer/XjEU6uc9u3sUG7OcJYCDm93_nIw=/2401x1351/smart/filters:no_upscale()/cloudfront-us-east-1.images.arcpublishing.com/morningstar/KD4XZLC72BDERAS3VXD6QM5MUY.png)
Healthcare
This sector includes biotechnology, pharmaceuticals, research services, home healthcare, hospitals, long-term-care facilities, and medical equipment and supplies.
Featured
Latest Company Reports
- PHGKoninklijke Philips NV ADR
Philips' Settlement Removes Some Uncertainty
- Rating
- Price
- $25.28
- Fair Value
- $57.82
- Uncertainty
- High
- Economic Moat
- Zxtxg
- Capital Allocation
- Dgjxgpb
- CRONCronos Group Inc
Cronos Is Unlikely to Generate Positive Adjusted EBITDA for the Foreseeable Future
- Rating
- Price
- $2.27
- Fair Value
- $7.30
- Uncertainty
- Very High
- Economic Moat
- Cjvf
- Capital Allocation
- Yvhhbgy
- CGCCanopy Growth Corp
US Deals Help Unlock Some Value but Doesn't Help Canopy Growth's Lagging Canadian Operations
- Rating
- Price
- $6.26
- Fair Value
- $9.10
- Uncertainty
- Extreme
- Economic Moat
- Zhl
- Capital Allocation
- Wmqb
- WBAWalgreens Boots Alliance Inc
Walgreens' Recovery Looks Uncertain as Retail Continues to Suffer and More Store Closures Underway
- Rating
- Price
- $11.57
- Fair Value
- $16.00
- Uncertainty
- Very High
- Economic Moat
- Wrzl
- Capital Allocation
- Kgvl
- TLRYTilray Brands Inc
Tilray's Mixed Portfolio Unlikely to Yield Synergies as Canadian Market Remains a Major Challenge
- Rating
- Price
- $1.65
- Fair Value
- $9.00
- Uncertainty
- Very High
- Economic Moat
- Vgjjn
- Capital Allocation
- Ftwdmvw
- ACBAurora Cannabis Inc
Aurora's Debt Load Severely Reduced, but Its Small Size Will Hinder Investment Ability and Growth
- Rating
- Price
- $4.52
- Fair Value
- $3.70
- Uncertainty
- Extreme
- Economic Moat
- Hwzxd
- Capital Allocation
- Bzm
- ILMNIllumina Inc
Illumina Spins Off Grail to Shareholders
- Rating
- Price
- $105.51
- Fair Value
- $474.00
- Uncertainty
- High
- Economic Moat
- Bltxrc
- Capital Allocation
- Rpxxcdf
- ALNYAlnylam Pharmaceuticals Inc
Narrow-Moat Alnylam's Positive Data in Vutrisiran ATTR-CM Trial Should Drive Strong Long-Term Growth
- Rating
- Price
- $247.61
- Fair Value
- $272.00
- Uncertainty
- High
- Economic Moat
- Jysrbbp
- Capital Allocation
- Stbwhjhl
- CURLFCuraleaf Holdings Inc
Curaleaf Positioned for Long-Term Growth From US and International Market Tailwinds
- Rating
- Price
- $3.78
- Fair Value
- $65.00
- Uncertainty
- Very High
- Economic Moat
- Mwql
- Capital Allocation
- Gpjlgsh
- GTBIFGreen Thumb Industries Inc
Green Thumb's Growth Should Benefit From Easing Federal Prohibition and New State Legalizations
- Rating
- Price
- $11.10
- Fair Value
- $52.00
- Uncertainty
- Very High
- Economic Moat
- Gtct
- Capital Allocation
- Qhnlhfztq
- LHLabcorp Holdings Inc
LabCorp Can Prioritize Diagnostics Now Without Distractions
- Rating
- Price
- $202.73
- Fair Value
- $265.14
- Uncertainty
- Medium
- Economic Moat
- Xgnwm
- Capital Allocation
- Gkxtymtbp
- QGENQiagen NV
Qiagen Still Pushing for Higher Growth Than Its End Markets
- Rating
- Price
- $40.70
- Fair Value
- $96.00
- Uncertainty
- Medium
- Economic Moat
- Wqnmg
- Capital Allocation
- Hljpqslmt
- TFXTeleflex Inc
Teleflex Is Expanding Its Portfolio of Surgical and Interventional Devices
- Rating
- Price
- $211.25
- Fair Value
- $536.00
- Uncertainty
- Medium
- Economic Moat
- Xjls
- Capital Allocation
- Yrty
- ATRAptarGroup Inc
Aptar's Profitability Improving Due to Pharma Growth and Cost Controls
- Rating
- Price
- $140.40
- Fair Value
- $247.00
- Uncertainty
- Medium
- Economic Moat
- Vnkfcy
- Capital Allocation
- Fqkhryx
- NVONovo Nordisk A/S ADR
Novo Nordisk's Cardiometabolic Innovation Supports a Wide Moat
- Rating
- Price
- $142.98
- Fair Value
- $74.00
- Uncertainty
- High
- Economic Moat
- Lfx
- Capital Allocation
- Dtqbdmwbql
Largest Stocks in the Healthcare Sector
1-Day Chart
|
Name
|
Industry
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
---|---|---|---|---|---|---|---|
Eli Lilly and Co
LLY
| Drug Manufacturers - General | Jxxsfmppwg | Dcydf | $816.4 Bil | |||
Novo Nordisk A/S ADR
NVO
| Biotechnology | Mgvnzqmxr | Gvvh | $636.9 Bil | |||
UnitedHealth Group Inc
UNH
| Healthcare Plans | Zlfdlldll | Ktzbtmw | $458.6 Bil | |||
Johnson & Johnson
JNJ
| Drug Manufacturers - General | Dhlzzbqn | Lth | $351.4 Bil | |||
Merck & Co Inc
MRK
| Drug Manufacturers - General | Ppzshbqq | Wtbkd | $323.5 Bil | |||
AbbVie Inc
ABBV
| Drug Manufacturers - General | Wqjjhgjc | Vhrw | $293.1 Bil | |||
AstraZeneca PLC ADR
AZN
| Drug Manufacturers - General | Tlszsnyg | Jvqmm | $236.9 Bil | |||
Novartis AG ADR
NVS
| Drug Manufacturers - General | Hmfdcsbw | Lpgjy | $217.9 Bil | |||
Thermo Fisher Scientific Inc
TMO
| Diagnostics & Research | Cttzbdxsk | Rkxj | $203.8 Bil | |||
Abbott Laboratories
ABT
| Medical Devices | Nnmdlxpq | Hyqfw | $179.5 Bil |
More in Healthcare
![](https://morningstar-morningstar-prod.web.arc-cdn.net/resizer/-rbO-Sf243DcW5i8OavwsebRGpw=/1201x1201/smart/filters:no_upscale()/cloudfront-us-east-1.images.arcpublishing.com/morningstar/RFJBWBYYTARXBNOTU6VL4VSE4Q.png)
19 Best Healthcare Companies to Invest In
These companies largely earn their competitive advantage from intangible assets, and their stocks are great choices for an investor’s watchlist.
![](https://morningstar-morningstar-prod.web.arc-cdn.net/resizer/5UO8GeXoCjL272KkTPW6j1qzhCs=/2401x2401/smart/filters:no_upscale()/cloudfront-us-east-1.images.arcpublishing.com/morningstar/KD4XZLC72BDERAS3VXD6QM5MUY.png)
Healthcare Stocks: Valuations Look Attractive Across Almost All Industries
Our top picks in the sector are Illumina, Moderna, and Zimmer Biomet.
![](https://morningstar-morningstar-prod.web.arc-cdn.net/resizer/5UO8GeXoCjL272KkTPW6j1qzhCs=/2401x2401/smart/filters:no_upscale()/cloudfront-us-east-1.images.arcpublishing.com/morningstar/KD4XZLC72BDERAS3VXD6QM5MUY.png)
Healthcare: Valuations Look Attractive Across Almost All Industries
We think the best healthcare stocks include Illumina, Moderna, and Zimmer Biomet.
![](https://morningstar-morningstar-prod.web.arc-cdn.net/resizer/kfY94E9esVbPiZpMCQIEfcImql4=/2401x2401/smart/filters:no_upscale()/cloudfront-us-east-1.images.arcpublishing.com/morningstar/HDPMMDGUA5CUHI254MRUHYEFWU.png)
3 Gold-Rated Funds Whose Managers Love Healthcare Stocks
Although the sector has suffered recently, it won’t hurt these well-run funds forever.
![](https://morningstar-morningstar-prod.web.arc-cdn.net/resizer/9xi4AV1kBhg7tj82UMFluymB5YA=/1201x1201/smart/filters:no_upscale()/cloudfront-us-east-1.images.arcpublishing.com/morningstar/22DGCGOHMJC7HHQIF2CERYV4JM.png)
Healthcare: Valuations Look Attractive Across Most Industries
We view the sector as undervalued, as the market is not fully appreciating its innovations.
![](https://morningstar-morningstar-prod.web.arc-cdn.net/resizer/gtAvkuIQb0yFOVIfYNxt0BZ_3mo=/1800x1800/smart/filters:no_upscale()/cloudfront-us-east-1.images.arcpublishing.com/morningstar/7B2BNWABPGQEALZ7BNPW5JW3PM.jpg)
A Checklist for Open Enrollment Season
If you’re signing up for employer-provided benefits, don’t just re-up for last year’s choices.
![](https://morningstar-morningstar-prod.web.arc-cdn.net/resizer/mjhTwRDtdz-CqFyqIcP2CkvayEI=/1201x1201/smart/filters:no_upscale()/cloudfront-us-east-1.images.arcpublishing.com/morningstar/L644DYLVFJDCLOIAOSBZUGFIEU.png)
8 Undervalued Quality Healthcare Stocks
These wide-moat healthcare stocks are trading below their fair value estimates.
![](https://morningstar-morningstar-prod.web.arc-cdn.net/resizer/9xi4AV1kBhg7tj82UMFluymB5YA=/1201x1201/smart/filters:no_upscale()/cloudfront-us-east-1.images.arcpublishing.com/morningstar/22DGCGOHMJC7HHQIF2CERYV4JM.png)
Healthcare Stock Outlook: Innovative Products and Defensive Nature Should Support Solid Results in Uncertain Times
We see plenty of opportunities in healthcare, especially in biopharma, healthcare providers, healthcare plans, and diagnostics and research.
![](https://morningstar-morningstar-prod.web.arc-cdn.net/resizer/nRZ1dv3IB6kbRo8-gB0syXbAbFs=/1200x1200/smart/filters:no_upscale()/cloudfront-us-east-1.images.arcpublishing.com/morningstar/4TYZEEXD3RGWNKTVNUJBWDUFAM.jpg)
Is UnitedHealth Stock a Buy, Sell, or Fairly Valued After Earnings?
Here’s what we think of UnitedHealth stock as surging demand for healthcare could strain near-term margins.
![](https://morningstar-morningstar-prod.web.arc-cdn.net/resizer/z_IQ9QJrRn0Fqn8xal_MGPKge0k=/1800x1800/smart/filters:no_upscale()/cloudfront-us-east-1.images.arcpublishing.com/morningstar/66O6YFGQPK4B3UEPMKAPFPKPOA.png)
2 Undervalued Medtech Stocks: Opportunities in Liquid Biopsy
Liquid biopsies could usher in a paradigm shift in cancer detection and grow exponentially.